Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Allo-HSCT with alternative donors in hematologic malignancy
NCT02487069Completed
- Sponsor
- Nanfang Hospital, Southern Medical University
- Start
- Jun 2015
- Primary completion
- Jan 2020
- Modality
- Stem Cell Therapies
- Countries
- 1
01
Overview
Open-label trial of allogeneic hematopoietic stem cells in acute leukemia, chronic myeloid leukemia (CML) and myelodysplastic syndrome (MDS), sponsored by Nanfang Hospital, Southern Medical University. Started Jun 2015; status: completed.
02
Drugs
allogeneic hematopoietic stem cells
03
Conditions
acute leukemiachronic myeloid leukemia (CML)myelodysplastic syndrome (MDS)
Beyond the preview
Go deeper on NCT02487069.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02487069.